For: | Caputo D. Hot topics in pancreatic cancer management. World J Gastrointest Surg 2023; 15(2): 121-126 [PMID: 36896312 DOI: 10.4240/wjgs.v15.i2.121] |
---|---|
URL: | https://www.wjgnet.com/2218-6182/full/v15/i2/121.htm |
Number | Citing Articles |
1 |
Kyriakos Kokkinogoulis, Aristomenis Kollas, David Simeonidis, Pavlos Papakostas, Kalliopi Platoni, Efstathios P. Efstathopoulos, Mersini Makropoulou. An overview of the feasibility of nanomedicine in pancreatic cancer theranostics. Exploration of Targeted Anti-tumor Therapy 2025; 6 doi: 10.37349/etat.2025.1002326
|
2 |
Shaohan Wu, Xiaofang Sun, Ruheng Hua, Chundong Hu, Lei Qin. DDX21 functions as a potential novel oncopromoter in pancreatic ductal adenocarcinoma: a comprehensive analysis of the DExD box family. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01204-9
|
3 |
Tanvi Gupta, Shang-Rung Wu, Li-Chan Chang, Forn-Chia Lin, Yan-Shen Shan, Chen-Sheng Yeh, Wen-Pin Su. Radiocleavable rare-earth nanoactivators targeting over-expressed folate receptors induce mitochondrial dysfunction and remodel immune suppressive microenvironment in pancreatic cancer. Journal of Nanobiotechnology 2025; 23(1) doi: 10.1186/s12951-025-03657-8
|